AL
Alumis Inc.
ALMS · NASDAQ
$9.90 -6.16% (-$0.65)
1M -61.25%
Market Cap $1.22B
P/E Ratio -
Div. Yield -
ROE 102.97%
Piotroski F-Score Weak
2/9Valuation
36 /100
Fair P/B 2.70x
P/S 165.18x
EV/EBITDA N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 5,933.45%
Op. margin 6,204.39%
FCF margin 4,755.33%
Quality
0 /100
Poor ROE 102.97%
ROA 78.30%
Asset turnover 0.01x
Debt
100 /100
Low Current ratio 6.74x
Debt/Equity 0.08x
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 186.73%
Profitable years 0
Beta -0.67x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALMS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Martin Babler
Employees
237
Headquarters
South San Francisco
Upcoming events
12 NOV
Earnings
Upcoming earnings report